"Our new board members' deep experience in our industry will be crucial as PDS continues to progress its clinical trial and partnership activities towards commercialization." , FRS Sir Richard is a preeminent leader in the pharmaceutical industry.
http://ift.tt/1zAD90d
http://ift.tt/1zAD90d
No comments:
Post a Comment